Decoy Therapeutics Inc. (NasdaqCM: DCOY)
Health Care · Biotechnology · US
$2.98
-16.76% today · -95.5% 1Y
Decoy Therapeutics Inc. (NasdaqCM: DCOY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.90M and employs 11 people.
Over the last twelve months the share price has lost 95.5%, trading between 3.51 and 106.20.
Tweenvest scores Decoy Therapeutics Inc. across four factors: quality 26/100, value 43/100. Its strongest factor is value.
DCOY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.90M
- Revenue (TTM)
- $227.63K
- P/E
- —
- EPS
- -57.12
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- $106.20
- 52-week low
- $3.51
- Avg volume (3M)
- —
- Shares outstanding
- 531.97K
- Employees
- 11
- Next earnings
- —
About Decoy Therapeutics Inc.
Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. is an early-stage biotechnology firm dedicated to tackling critical unmet medical needs. The company employs cutting-edge machine learning and AI technologies, alongside accelerated synthesis methods, to swiftly design, engineer, and manufacture innovative peptide conjugate drug candidates.
- ISIN
- US79400X6022
- Listed since
- Jan 29, 2015
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.